Interview about the ObsERV platform with Per Norlén
In a 7 minutes conversation with Redeye, our CEO Per Norlén explains how leftovers from ancient viruses that infected our ancestors, so-called ERVs, can help us develop an efficient cancer treatment today and in the future.
Jan 19, 2023
Redeye Fight Cancer – January 2023
Our CEO, Per Norlén, presented at Redeye Fight Cancer on January 19, 2023.
Dec 5, 2022
Get to know CEO Per Norlén
Redeye interviewed Evaxion’s newly appointed CEO, Per Norlén, about his background, reasons for joining the company, and hopes for the future
Nov 29, 2022
BioStock Life Science Fall Summit 2022
Our CEO, Per Norlén, presented the company at BioStock Life Science Fall Summit 2022 in Lund, Sweden. In the video, you can hear more about how we use the power of our AI to make a unique and personalized treatment for each patient